• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » All Party Parliamentary Group established to raise profile of U.K. life sciences sector

All Party Parliamentary Group established to raise profile of U.K. life sciences sector

July 22, 2015
CenterWatch Staff

The All Party Parliamentary Group (APPG) on Life Sciences has launched to raise awareness and understanding of the valuable contribution the life sciences sector provides to the health and the wealth of the U.K.

Kit Malthouse, MP, chair of the APPG, said, “Life sciences is the quintessential, high-tech, innovative sector that we should prioritize for the 21st-century economy. In addition to its economic impact, at its heart are innovations and therapies that benefit patients and the public.”

Life Sciences U.K. (LSUK) is made up of four trade associations for the life sciences sector in the U.K.: Association of British Healthcare Industries (ABHI), Association of the British Pharmaceutical Industry (ABPI), the BioIndustry Association (BIA) and the British In Vitro Diagnostics Association (BIVDA).

“Collaborative working between industry and government is essential to create a national healthcare system that truly delivers not only the best possible outcomes for patients, but provides a fertile environment for U.K. businesses to advance medical technologies,” said Peter Ellingworth, CEO, ABHI.

Doris-Ann Williams, CEO, BIVDA, said, “For the U.K. to truly become a global leader in the life sciences, then effective engagement between policy makers and life sciences industry is essential. The APPG is a vital step towards this highly achievable goal.”

APPGs are informal cross-party groups that have no official status within Parliament. They are run by and for Members of the Commons and Lords, though many involve individuals and organizations from outside Parliament in their administration and activities.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing